Cyclodextrins in drug delivery: applications in gene and combination therapy.
Ontology highlight
ABSTRACT: Gene therapy is a powerful tool against genetic disorders and cancer, targeting the source of the disease rather than just treating the symptoms. While much of the initial success of gene delivery relied on viral vectors, non-viral vectors are emerging as promising gene delivery systems for efficacious treatment with decreased toxicity concerns. However, the delivery of genetic material is still challenging, and there is a need for vectors with enhanced targeting, reduced toxicity, and controlled release. In this article, we highlight current work in gene therapy which utilizes the cyclic oligosaccharide molecule cyclodextrin (CD). With a number of unique abilities, such as hosting small molecule drugs, acting as a linker or modular component, reducing immunogenicity, and disrupting membra
SUBMITTER: Haley RM
PROVIDER: S-EPMC7524011 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA